New Evidence With BTK Inhibitor Therapy in CLL and MCL From ASCO 2022
CCO Oncology Podcast - Ein Podcast von Clinical Care Options

Kategorien:
Gain insight into expert faculty perspectives as they discuss recent key studies from ASCO 2022 on BTK inhibition in chronic lymphocytic leukemia and mantle cell lymphoma and their potential implications for clinical practice.